Nalini Venkatesan
- Ophthalmology top 5%
- Ocular Oncology and Treatments 17
-
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 2
-
- Cancer-related Molecular Pathways 8
-
- interferon and immune responses 5
-
- Glioma Diagnosis and Treatment 2
-
- Neuroblastoma Research and Treatments 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Subramanian KrishnakumarVikas KhetanAdithi MohanMallikarjuna KandalamP. R. DeepaJyotirmay BiswasMadavan VasudevanUmashankar Vetrivel
- Cited by
- OphthalmologyCancer ResearchOncology
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Cancer (2 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Nalini Venkatesan
24 papers receiving 440 citations
Peers
Comparison fields: 5 of 61
- Ophthalmology 162
- Cancer Research 146
- Oncology 141
- Immunology 107
- Molecular Biology 259
Countries citing papers authored by Nalini Venkatesan
This map shows the geographic impact of Nalini Venkatesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nalini Venkatesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nalini Venkatesan more than expected).
Fields of papers citing papers by Nalini Venkatesan
This network shows the impact of papers produced by Nalini Venkatesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nalini Venkatesan. The network helps show where Nalini Venkatesan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nalini Venkatesan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 5 | |
| 4 | 2016 | 37 | |
| 5 | 2016 | 9 | |
| 6 | 2016 | 10 | |
| 7 | Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy | 2015 | 3 |
| 8 | 2014 | 11 | |
| 9 | 2013 | 27 | |
| 10 | Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells. | 2012 | 19 |
| 11 | 2009 | 15 | |
| 12 | 2008 | 6 | |
| 13 | 2008 | 23 | |
| 14 | 2007 | 14 | |
| 15 | 2006 | 21 | |
| 16 | 2006 | 5 | |
| 17 | 2006 | 12 | |
| 18 | 2006 | 32 | |
| 19 | 2005 | 14 | |
| 20 | 2004 | 11 |
About Nalini Venkatesan
Nalini Venkatesan is a scholar working on Ophthalmology, Cancer Research and Oncology, having authored 25 papers that have together received 445 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (17 papers), Cancer-related Molecular Pathways (8 papers), MicroRNA in disease regulation (7 papers), interferon and immune responses (5 papers), Cancer, Hypoxia, and Metabolism (2 papers), Glioma Diagnosis and Treatment (2 papers), Neuroblastoma Research and Treatments (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Ophthalmology (162 citations), Cancer Research (146 citations) and Oncology (141 citations). Nalini Venkatesan has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Subramanian Krishnakumar, Vikas Khetan, Adithi Mohan, Mallikarjuna Kandalam, P. R. Deepa, Jyotirmay Biswas, Madavan Vasudevan, Umashankar Vetrivel, Hema L. Ramkumar and M. Ashwin Reddy. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.